Humanoid Robotics for Healthcare Efficiency Improvements

(HEALTH Trial)

Enrolling by invitation at 3 trial locations

Age: Any Age

Sex: Any

Trial Phase: Phase 2

Sponsor: Truway Health, Inc.

Disqualifiers: Cognitive impairment, Infectious disease, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Prior Safety Data This treatment has passed at least one previous human trial

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests humanoid robots in healthcare roles to assess their assistance with patient care, sanitation, and intake processes. The goal is to evaluate their impact on efficiency, environmental standards, and daily operations. Different locations will test robots with enhancements, such as improved skin sensitivity or cognitive abilities, to evaluate their performance in various tasks. Facility staff willing to interact with these robots and provide feedback for 90 days might be a good fit. As a Phase 2 trial, this research measures the robots' effectiveness in an initial, smaller group, offering participants a chance to contribute to innovative healthcare solutions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It would be best to discuss this with the trial coordinators for clarification.

What prior data suggests that humanoid robotics are safe for healthcare settings?

A previous study showed that humanoid robots use advanced sensors and smart technology to improve safety. These sensors detect and prevent dangers, making human interactions safer. For the New York Facility's use of synthetic skin, research shows that this sensitive skin enhances safety during human-robot interactions. The skin is designed to feel touch, helping to prevent accidents.

Another study explored making humanoid robots smarter. These improvements help robots learn and respond better to their surroundings. While this study doesn't provide specific safety numbers, it highlights ongoing efforts to make robots both smarter and safer.

Research on ESG (Environmental, Social, and Governance) optimization shows that humanoid robots enhance safety by reducing the need for humans in dangerous places. These robots can monitor safety and energy use, leading to safer operations.

Overall, the studies suggest that humanoid robots are designed with safety in mind. They use technology to reduce risks and improve interactions with humans. While specific safety statistics are not provided, the focus on safety features is evident in all these studies. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how humanoid robotics can revolutionize healthcare efficiency. Unlike traditional methods that rely heavily on human labor, these humanoid units perform specific roles such as reception, intake coordination, sanitation, and logistics. The unique features of this trial include the use of wage token calibration based on biometric audits, keratinocyte-based skin cell enhancements for improved tactile sensitivity, and iPSC-derived stem cell dips for cognitive and adaptive learning improvements. Additionally, an emphasis on ESG compliance and energy optimization sets these robots apart, potentially leading to more sustainable healthcare practices. By integrating advanced robotics with ESG monitoring, this approach aims to enhance operational efficiency and reduce environmental impact in healthcare settings.

What evidence suggests that this trial's treatments could be effective?

Research shows that robots are making healthcare more efficient and effective. In this trial, the Tokyo Facility will test AI and blockchain to help humanoid units complete tasks more accurately and with fewer mistakes. The New York Facility will evaluate technology that mimics human skin to improve how robots interact with patients. The Austin Facility will explore stem cell technology to enhance robots' thinking skills, making them better at learning and adapting to new tasks. Lastly, the Frankfurt Facility will focus on using resources wisely and following environmental rules, demonstrating that robots can be eco-friendly. Together, these technologies are tested in this trial to improve healthcare through innovation. ^{3 6 7 8 9}

Who Is on the Research Team?

Gavin C Solomon, President & CEO

Principal Investigator

Truway Health, Inc.

Are You a Good Fit for This Trial?

This trial is for healthcare settings looking to improve mobility, efficiency, hygiene, and robotic surgery. Participants should be interested in integrating humanoid robotics into patient care and sanitation workflows.

Inclusion Criteria

Able to provide informed consent

Facility staff, clinical auditors, ESG observers, or coalition stakeholders

Willing to interact with humanoid robotics in clinical workflows

Exclusion Criteria

Prior adverse reaction to biotech-enhanced robotics

Involvement in conflicting clinical trials

Inability to comply with protocol procedures or coalition transparency requirements

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Deployment

Humanoid units are deployed in various roles across metro facilities to evaluate performance in patient intake, sanitation, and mobility assistance.

30 days

Continuous monitoring

Performance Evaluation

Biometric audit scores are assessed across five dimensions, and wage tokens are distributed based on performance.

60 days

Continuous monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

30 days

What Are the Treatments Tested in This Trial?

Interventions

• ESG Compliance Monitoring

Trial Overview The study tests the use of humanoid robots with biotech enhancements in healthcare. It measures their performance on patient care, cleanliness, and administrative tasks while monitoring environmental and social governance compliance.

How Is the Trial Designed?

Group I: Tokyo Facility - Wage Token Calibration Experimental Treatment 1 Intervention

Humanoid units deployed in public interface and intake roles. Wage tokens minted based on biometric audit scores and task completion. Assigned Roles: Receptionist, intake coordinator Biometric Focus: Wage token distribution, interaction scoring

Group II: New York Facility - Skin Cell Deployment Experimental Treatment 1 Intervention

Humanoid units deployed in patient intake and sanitation roles. Enhanced with keratinocyte-based skin cell dips to improve tactile sensitivity and surface regeneration. Assigned Roles: Intake assistant, sanitation technician Biometric Focus: Motor function, ESG compliance

Group III: Frankfurt Facility - ESG Optimization Experimental Treatment 1 Intervention

Humanoid units deployed in ESG-linked sanitation and logistics roles. Monitored for energy usage, carbon offset, and protocol adherence. Assigned Roles: ESG sanitation, logistics handler Biometric Focus: ESG compliance, human interaction

Group IV: Austin Facility - Stem Cell Cognitive Enhancement Experimental Treatment 1 Intervention

Humanoid units deployed in mobility and R\&D support roles. Enhanced with iPSC-derived stem cell dips targeting neural responsiveness and adaptive learning. Assigned Roles: Mobility assistant, lab technician Biometric Focus: Cognitive response, biotech retention

Who Is Running the Clinical Trial?

Truway Health, Inc.

Lead Sponsor

Citations

1. withpower.com withpower.com/trial/early-phase-1-mobility-impairments-9-2025-f80e8

Humanoid Robotics for Healthcare Efficiency Improvements This trial is for healthcare settings looking to improve mobility, efficiency, hygiene, and robotic surgery. Participants should be interested ...

2. humanoidroboticstechnology.com humanoidroboticstechnology.com/winners/

Winners of the Humanoid Robotics Industry Awards 2025 The goal is to deploy these robots in healthcare, retail, hospitality, etc., to do tasks like logistical assistance, companionship, navigation, while ensuring ...

3. youtube.com youtube.com/watch?v=-NxsFJWNLCI

Humanoid Robots Redefining the Future of Healthcare I'm Ro a humanoid robot designed to interact with the human environment in a natural efficient and collaborative way.

4. ieee-jas.net ieee-jas.net/article/doi/10.1109/JAS.2023.124140?ref=scientific.media

Advancements in Humanoid Robots: A Comprehensive ... This paper provides a comprehensive review of the current status, advancements, and future prospects of humanoid robots, highlighting their ...

5. ache-cahl.org ache-cahl.org/articles/humanoid-robots-in-healthcare-the-future-is-here-but-are-we-ready/

Humanoid Robots in Healthcare: The Future is Here—But ... As robotics expert Evan Ackerman points out, no humanoid robot has successfully operated in the unpredictable environment of patient care.

6. sciencedirect.com sciencedirect.com/science/article/pii/S0736584523000856

Cognitive neuroscience and robotics: Advancements and ... This paper provides a comprehensive review of the past and the current status at the intersection of robotics, neuroscience, and artificial intelligence

7. cell.com cell.com/the-innovation/fulltext/S2666-6758(24)00190-5

AI-assisted flexible electronics in humanoid robot heads for ... We have traced the recent developments of humanoid robot heads for facial expressions, discussed major challenges in embodied AI and flexible electronics.

8. ncbi.nlm.nih.gov ncbi.nlm.nih.gov/books/NBK299034/

Humanoid Robotics and Neuroscience: Science, Engineering ... CB is a humanoid robot created for exploring the underlying processing of the human brain while dealing with the real world. We place our robotic investigations ...

9. mdpi.com mdpi.com/2079-9292/13/3/542

Intelligent Robotics—A Systematic Review of Emerging ... This systematic literature review aims to analyze emerging technologies and trends in intelligent robotics, addressing key research questions, identifying ...